CD40LG and neoplasm: Additionally, downregulation of the IgE, IgG, IgD, and IgM protein complex signaling pathways indicated a decreased ability to secrete tumor-infiltrating immunoglobulin, enhancing proliferation and potentially contributing to rapid tumor recurrence after CAR-T cell therapy (19).